Strauss SJ - Search Results

1

Current approaches to management of bone sarcoma in adolescent and young adult patients.

Ingley KM, Maleddu A, Grange FL, Gerrand C, Bleyer A, Yasmin E, Whelan J, Strauss SJ. Ingley KM, et al. Among authors: strauss sj. Pediatr Blood Cancer. 2022 Feb;69(2):e29442. doi: 10.1002/pbc.29442. Epub 2021 Nov 12. Pediatr Blood Cancer. 2022. PMID: 34767314 Review.

2

Single center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties.

Strauss SJ, McTiernan A, Driver D, Hall-Craggs M, Sandison A, Cassoni AM, Kilby A, Michelagnoli M, Pringle J, Cobb J, Briggs T, Cannon S, Witt J, Whelan JS. Strauss SJ, et al. J Clin Oncol. 2003 Aug 1;21(15):2974-81. doi: 10.1200/JCO.2003.04.106. J Clin Oncol. 2003. PMID: 12885818

3

Late relapse of osteosarcoma: implications for follow-up and screening.

Strauss SJ, McTiernan A, Whelan JS. Strauss SJ, et al. Pediatr Blood Cancer. 2004 Nov;43(6):692-7. doi: 10.1002/pbc.20154. Pediatr Blood Cancer. 2004. PMID: 15390283

4

Experimental therapies in Ewing's sarcoma.

Windsor R, Strauss S, Seddon B, Whelan J. Windsor R, et al. Expert Opin Investig Drugs. 2009 Feb;18(2):143-59. doi: 10.1517/13543780802715784. Expert Opin Investig Drugs. 2009. PMID: 19236262 Review.

5

Understanding micrometastatic disease and Anoikis resistance in ewing family of tumors and osteosarcoma.

Strauss SJ, Ng T, Mendoza-Naranjo A, Whelan J, Sorensen PH. Strauss SJ, et al. Oncologist. 2010;15(6):627-35. doi: 10.1634/theoncologist.2010-0093. Epub 2010 May 17. Oncologist. 2010. PMID: 20479280 Free PMC article. Review.

6

Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study.

Windsor RE, Strauss SJ, Kallis C, Wood NE, Whelan JS. Windsor RE, et al. Among authors: strauss sj. Cancer. 2012 Apr 1;118(7):1856-67. doi: 10.1002/cncr.26472. Epub 2011 Sep 1. Cancer. 2012. PMID: 21887680 Free article.

7

Incidence and survival of malignant bone sarcomas in England 1979-2007.

Whelan J, McTiernan A, Cooper N, Wong YK, Francis M, Vernon S, Strauss SJ. Whelan J, et al. Among authors: strauss sj. Int J Cancer. 2012 Aug 15;131(4):E508-17. doi: 10.1002/ijc.26426. Epub 2011 Nov 2. Int J Cancer. 2012. PMID: 21913189 Free article.

8

Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?

Frezza AM, Beale T, Bomanji J, Jay A, Kalavrezos N, Dileo P, Whelan J, Strauss SJ. Frezza AM, et al. Among authors: strauss sj. BMC Cancer. 2014 Jan 15;14:23. doi: 10.1186/1471-2407-14-23. BMC Cancer. 2014. PMID: 24422949 Free PMC article.

9

What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients.

Rothermundt C, Whelan JS, Dileo P, Strauss SJ, Coleman J, Briggs TW, Haile SR, Seddon BM. Rothermundt C, et al. Among authors: strauss sj. Br J Cancer. 2014 May 13;110(10):2420-6. doi: 10.1038/bjc.2014.200. Epub 2014 Apr 15. Br J Cancer. 2014. PMID: 24736584 Free PMC article.

10

Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy.

Fernanda Amary M, Ye H, Berisha F, Khatri B, Forbes G, Lehovsky K, Frezza AM, Behjati S, Tarpey P, Pillay N, Campbell PJ, Tirabosco R, Presneau N, Strauss SJ, Flanagan AM. Fernanda Amary M, et al. Among authors: strauss sj. Cancer Med. 2014 Aug;3(4):980-7. doi: 10.1002/cam4.268. Epub 2014 May 27. Cancer Med. 2014. PMID: 24861215 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page